Women's Health-Focused Novel Bispecific Antibody Developer – Innovator Biotech
Fab Biopharma develops a novel class of bispecific soluble receptor therapeutics focused on combating Sjögren’s Syndrome and other autoimmune disorders that disproportionately affect women. The small startup needed a brand and digital platform to grow its team and attract funding.
Fab’s go-to-market strategy highlighted the company’s small but dedicated and passionate team and the potential of its proprietary dual-targeting soluble receptor drug platform. This was underpinned by thought leadership and data supporting Fab’s dedication to medical equity and commitment to reimagining biopharma through a female perspective.
We positioned Fab Biopharma and its team as a collection of cutting-edge innovators with a deep well of expertise serving a promising biotherapeutic niche.